Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Genome sequencing, i.e. the decoding of DNA, is becoming cheaper. This is widening the applications of DNA analysis, for example in diagnosing conditions and in making drug development more targeted.

But more analysis also means huge amounts of data, increasing numbers of data formats, storage costs and greater analytical complexity. With the support of Innosuisse, the Vaudbased start-up GenomSys is developing software based on the new MPEG-G standard, which massively simplifies the processing and distribution of DNA data. “With MPEG-G, DNA data is extremely compressed, enabling faster data exchange and more efficient data analysis,” explains GenomSys co-founder Dr Claudio Alberti. “Our software also offers easy and secure access to individual data and a high degree of interoperability.”

More information on the news you will find here.

Schedule a call

[contact-form-7 id="224" title="contact call"]